BERLIN : Germany will from Wednesday limit the use of AstraZeneca's COVID-19 vaccine to people aged 60 and above as well as high-priority groups following further reports of a rare brain blood disorder."We have to be able trust the vaccines," Chancellor Angela Merkel told journalists at a news conference on Tuesday. "And transparency is the best way to deal with such a situation," she added.Acting on advice from Germany's vaccine committee, known as STIKO, Germany's federal and state health ministries agreed that under 60-year-olds should only receive the AstraZeneca vaccine if they belong to high-priority groups, which include high-risk patients and medical workers, in consultation with a doctor.People aged below 60 who have already.